Previous close | 17.52 |
Open | 17.53 |
Bid | 17.44 x 1217900 |
Ask | 16.77 x 975200 |
Day's range | 17.46 - 17.67 |
52-week range | 13.80 - 18.42 |
Volume | |
Avg. volume | 3,245,647 |
Market cap | 26.202B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 12.92 |
EPS (TTM) | 1.35 |
Earnings date | 15 Feb 2024 |
Forward dividend & yield | 0.62 (3.56%) |
Ex-dividend date | 06 Mar 2024 |
1y target est | 19.60 |
Amidst a challenging day for the ASX200, which saw a decline of 1.1 percent across all sectors, and rising living costs impacting households, investors might find solace in dividend stocks that can offer potential income stability. In this context, exploring strong performers like Nick Scali among others becomes particularly relevant as they may provide a cushion against market volatility and economic pressures.
QBE North America today announced the launch of its Healthcare Liability practice, a suite of coverages designed to meet the unique needs of healthcare organizations. The practice, which consists of a dedicated team and core products, is part of QBE's longstanding commitment to help customers manage evolving risks and foster resilience.
QBE announced today that applications are now open for the 2024 QBE AcceliCITY Resilience Challenge, powered by Leading Cities. Entrepreneurs with pioneering ideas that leverage smart-city solutions to tackle urban risk, equity and sustainability are encouraged to apply before the deadline on April 30, at AcceliCITY.com.